China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 26.55
(0.23%)
CNY 26.55
(0.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 484.55 Million CNY | -35.25% |
| 2022 | 748.34 Million CNY | 6.71% |
| 2021 | 701.29 Million CNY | -27.41% |
| 2020 | 966.07 Million CNY | -23.82% |
| 2019 | 1.26 Billion CNY | -2.65% |
| 2018 | 1.3 Billion CNY | 9.89% |
| 2017 | 1.18 Billion CNY | 312.58% |
| 2016 | 287.29 Million CNY | 2.57% |
| 2015 | 280.1 Million CNY | 198.3% |
| 2014 | 93.9 Million CNY | -40.51% |
| 2013 | 157.84 Million CNY | 511.75% |
| 2012 | 25.8 Million CNY | -62.32% |
| 2011 | 68.48 Million CNY | -29.97% |
| 2010 | 97.78 Million CNY | -35.64% |
| 2009 | 151.93 Million CNY | 77.72% |
| 2008 | 85.49 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 575.96 Million CNY | 11.5% |
| 2024 Q2 | 516.57 Million CNY | -0.71% |
| 2024 Q1 | 520.26 Million CNY | 7.37% |
| 2023 Q4 | 484.55 Million CNY | -20.6% |
| 2023 FY | 484.55 Million CNY | -35.25% |
| 2023 Q1 | 771.23 Million CNY | 3.06% |
| 2023 Q2 | 685.02 Million CNY | -11.18% |
| 2023 Q3 | 610.24 Million CNY | -10.92% |
| 2022 FY | 748.34 Million CNY | 6.71% |
| 2022 Q1 | 652.06 Million CNY | -7.02% |
| 2022 Q2 | 719.46 Million CNY | 10.34% |
| 2022 Q3 | 711.31 Million CNY | -1.13% |
| 2022 Q4 | 748.34 Million CNY | 5.21% |
| 2021 Q3 | 901.59 Million CNY | 1.61% |
| 2021 Q2 | 887.27 Million CNY | 25.19% |
| 2021 FY | 701.29 Million CNY | -27.41% |
| 2021 Q1 | 708.74 Million CNY | -26.64% |
| 2021 Q4 | 701.29 Million CNY | -22.22% |
| 2020 Q2 | 1.32 Billion CNY | -7.72% |
| 2020 Q1 | 1.43 Billion CNY | 13.04% |
| 2020 FY | 966.07 Million CNY | -23.82% |
| 2020 Q3 | 1.16 Billion CNY | -11.96% |
| 2020 Q4 | 966.07 Million CNY | -17.04% |
| 2019 Q1 | 1.3 Billion CNY | 0.16% |
| 2019 Q3 | 1.29 Billion CNY | 0.35% |
| 2019 Q4 | 1.26 Billion CNY | -2.38% |
| 2019 FY | 1.26 Billion CNY | -2.65% |
| 2019 Q2 | 1.29 Billion CNY | -0.78% |
| 2018 Q3 | 1.56 Billion CNY | -0.54% |
| 2018 FY | 1.3 Billion CNY | 9.89% |
| 2018 Q2 | 1.57 Billion CNY | 31.06% |
| 2018 Q1 | 1.19 Billion CNY | 1.14% |
| 2018 Q4 | 1.3 Billion CNY | -16.65% |
| 2017 Q4 | 1.18 Billion CNY | 85.9% |
| 2017 Q3 | 637.6 Million CNY | -0.32% |
| 2017 Q1 | 572.21 Million CNY | 99.17% |
| 2017 Q2 | 639.66 Million CNY | 11.79% |
| 2017 FY | 1.18 Billion CNY | 312.58% |
| 2016 Q4 | 287.29 Million CNY | 21.01% |
| 2016 Q2 | 253.91 Million CNY | 22.54% |
| 2016 FY | 287.29 Million CNY | 2.57% |
| 2016 Q1 | 207.21 Million CNY | -26.02% |
| 2016 Q3 | 237.42 Million CNY | -6.5% |
| 2015 Q2 | 140.32 Million CNY | 80.02% |
| 2015 Q1 | 77.94 Million CNY | -16.99% |
| 2015 Q4 | 280.1 Million CNY | 107.38% |
| 2015 FY | 280.1 Million CNY | 198.3% |
| 2015 Q3 | 135.06 Million CNY | -3.74% |
| 2014 FY | 93.9 Million CNY | -40.51% |
| 2014 Q2 | 72.06 Million CNY | 0.06% |
| 2014 Q4 | 93.9 Million CNY | 17.87% |
| 2014 Q3 | 79.66 Million CNY | 10.55% |
| 2014 Q1 | 72.01 Million CNY | -54.38% |
| 2013 Q2 | 35.9 Million CNY | 11.16% |
| 2013 FY | 157.84 Million CNY | 511.75% |
| 2013 Q4 | 157.84 Million CNY | 141.64% |
| 2013 Q3 | 65.32 Million CNY | 81.93% |
| 2013 Q1 | 32.3 Million CNY | 25.18% |
| 2012 FY | 25.8 Million CNY | -62.32% |
| 2012 Q2 | 24.54 Million CNY | -62.86% |
| 2012 Q1 | 66.09 Million CNY | -3.49% |
| 2012 Q4 | 25.8 Million CNY | -12.8% |
| 2012 Q3 | 29.58 Million CNY | 20.55% |
| 2011 FY | 68.48 Million CNY | -29.97% |
| 2011 Q4 | 68.48 Million CNY | 0.0% |
| 2010 FY | 97.78 Million CNY | -35.64% |
| 2009 FY | 151.93 Million CNY | 77.72% |
| 2008 FY | 85.49 Million CNY | 0.0% |